Digital follow-upOn-site follow-upResistance exercise
Digital follow-up: See the arm/group description.
On-site follow-up: See the arm/group description.
Resistance exercise: See the arm/group description.
Study summary
Resistance exercise has been shown to improve several important health variables after cancer and cancer related treatment, but unfortunately the adherence to resistance exercise is low. Typical reported exercise barriers are inconvenient location (e.g. long distance from home), exercise at an unfavorable time of the day, inadequate access to cancer-specific exercise and insufficient recommendations from healthcare providers. Thus, there is need for more research on resistance exercise with an alternative approach in cancer rehabilitation, that potentially can target a broad range of patients, despite their domicile. In Norway, the foundation "Active against cancer" has established exercise locations targeting cancer patients in several hospitals, and today they also offer digital home-based exercise sessions. Therefore, the overall research objectives are to compare the efficacy of a 12 weeks digital, home-based resistance exercise program for cancer patients after treatment on functional, mental, and metabolic health, compared to the same program conducted in a studio under guidance of an instructor. The primary aim is to compare the effect on exercise adherence between digital home-based exercise program and the on-site guided program in cancer patients after treatment. Secondary aims are to compare the two groups on several functional health outcomes, mental health outcomes and metabolic health markers. In addition to the randomized controlled trial, the project includes two non-randomized cohorts - patients undergoing active cancer treatment, and patients living more than 20 km from an exercise location - who follow the digital home-based program and the same test protocol.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* ≥ 18 years and able to give informed consent
* Previously diagnosed with any form of cancer and having completed systemic chemotherapy, immunotherapy or targeted therapies or local radiotherapy not more than 5 years earlier
* Living within 20 km of one of the exercise locations (Lillehammer, Gjøvik, or Hamar)
* Life expectancy of more than 12 months
* Access to digital equipment at home (e.g. PC and/or tablet) and an email address, enabling participation on the digital exercise platform
* Able to understand the Norwegian language
Exclusion Criteria:
* Co-morbidities prohibiting exercise according to the protocol, such as serious cardiac, pulmonary, or other organ diseases
* Conditions caused by the cancer that prohibits exercise, such as recent major surgery, fractures, or pain
* Still undergoing active cancer treatment
* Life expectancy of less than 12 months
* Reduced mental capacity such that the participant is unable to give informed consent and follow the program
* Has performed regular strength training (two or more times per week) within the last three months
Note on reference groups:
In addition to the randomized controlled trial, the study includes two non-randomized reference groups that are allocated to the digital home-based intervention only and undergo the same test protocol as the randomized participants. These are: (i) patients undergoing active cancer treatment, and (ii) patients who have completed treatment but live more than 20 km from an exercise location. Reference-group participants must otherwise meet the same inclusion criteria regarding age, cancer diagnosis, life expectancy, digital access, and language, and are subject to the same exclusion criteria, except that ongoing active treatment and distance from an exercise location are permitted as defining features of the respective groups. Patients undergoing active cancer treatment that is expected to confer a high risk of bone marrow suppression - leading to infections, bleeding, and/or severely reduced physical capacity - are excluded.
Primary outcome measure(s)
Exercise adherence — Baseline to post-test (0-12 weeks) Percentage of completed prescribed exercise sessions.
Trial sites (4)
Facility
City
Region
Status
Innlandet Hospital Trust/ Pusterommet Gjøvik
Gjøvik
Norway
The Hamar Training Centre
Hamar
Norway
Aktivklinikken
Lillehammer
Norway
Inland Norway University of Applied Sciences
Lillehammer
Norway
More Inland Norway University of Applied Sciences trials in Norway
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
